Navigation Links
Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
Date:3/13/2009

SALT LAKE CITY, March 13 /PRNewswire/ -- Prolexys Pharmaceuticals announced today the publication of the discovery of genes that are likely to have a role in the aging process of humans. The findings result from research on the human equivalents of proteins from simple animals which confer long life in those species. The evidence suggests that these proteins are more likely to interact with other proteins in a large atlas of mapped interactions. Furthermore, the investigators were able to show that the protein associations also correlate with differences in gene expression between young and old humans. Though the existence of longevity-extending genes has been known for experimental organisms such as yeast, roundworms and flies, this is the first demonstration that similar genes have a role in the aging process of humans.

The proteins involved are defined as a network of 175 human equivalents of known invertebrate longevity genes and 2163 additional proteins in a complex network involving 3271 interactions. The research, published in the March 13, 2009 issue of PLoS Genetics, was a collaboration of scientists at Prolexys, The Buck Institute for Age Research in Novato, California, University of California in Berkeley and McMaster University in Hamilton, Ontario.

"This work continues to demonstrate that high-throughput screening for protein interactions combined with genetic and functional validation provides an opportunity to investigate complex biological processes such as aging. Furthermore, we would like to encourage scientists interested in aging and longevity to mine these data made available in the study," said Dr. Sudhir Sahasrabudhe, Chief Scientific Officer of Prolexys Pharmaceuticals.

"This establishes a similarity in aging process among diverse species that is perhaps a lot broader than many of us may have expected," says Robert Hughes, lead author of the study.


'/>"/>
SOURCE Prolexys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Covance Purchases Equity Stake in Caprion Proteomics
2. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
3. Sigma-Aldrich Announces New Prestige Antibodies(TM) Line for Proteomics and Cell Biology Researchers
4. Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site
5. Angiotech announces positive results from Bio-Seal(TM) clinical study
6. Proteon Therapeutics Completes $38M Equity Financing; Initiates Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients and Signs Option Agreement With Major Pharmaceutical Company
7. Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma
8. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
9. QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
10. New Study Reports Improved Patient Outcomes for Breast Cancer Patients
11. Mouse study reveals genetic component of empathy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sino...rovider of vaccines, announced today that it execu...novac (Dalian) Vaccine,Technology Co., Ltd. (Sinov...,and commercialize human-use vaccines. Sinovac wil...oping and commercializing world-class vaccines; th...
(Date:11/25/2009)...N DIEGO, Nov. 25 Ardea B...that Barry D. Quart, Pharm.D., president and chief...ray 21st Annual Health Care Conference. , ,Presen... Annual Health Care Conference,Date: Tuesday,...e,Location: The New York Palace Hotel, New York, ...
(Date:11/24/2009)... HOUSTON, Nov. 24 IES (N...ctrical and communications systems and services fo...ts, announced today that its commercial business g...rcon JV to install the electrical systems for the ...y at the U.S. Army Medical Research Institute of I...
(Date:11/24/2009)... The New York investment bank KTA Capita...s agreed an AU$6.7 mil convertible note private pl...ivate placement was arranged by KTA Capital as Neu... New York (PRWEB) November 23... KTA Capital, LLC ("KTA Capital") has an...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...NCISCO, Calif., June 16 Monogram,Biosciences, Inc...ed to the,enhanced performance of the company,s HI...tion at the 17th International HIV Drug Resistance... commercially upon FDA approval of,Selzentry(TM) (...t, in,August 2007. Recent enhancements to Monogram...
...edical Device Executive and Former CFO of Thermage...ncluding Non-Invasive Aesthetics, PALO ALTO, Cali...bsorbable implants for the fixation of soft tissue...e markets, announced today the,appointment of Laur...o,serve as a member of the company,s Board of Dire...
... acquisition system offers revolutionary orthotic ...on, ANAHEIM, Calif., June 13 PAL Health Technolo...ve away a free unit at the Western,Podiatric Medic...t the,Disneyland Hotel., Xtremityscan is a digita...quire three-dimensional foot shapes in seconds, wi...
Other Biology Technology:Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 2Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 3Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 4Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 5Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy 6Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 2Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 3PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress 2
(Date:11/24/2009)...h food is a matter of debate. A high-profile study... percent of their carbon from trees and leaves, ev...al and aquatic ecosystems. , But new research fr...likely to be true. Algae provide a much richer die...search published this week in the Proceedings of ...
(Date:11/23/2009)...h presents strong evidence that the "synergistic" ...fic-related pollution and indoor endotoxin causes ...r exposure alone. , Environmental health scien... of Medicine have shown that children exposed to b...ndoor endotoxin during early life are six times mo...
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Popular Prescription Drug Discount Card Now Available in Arizona Online 50974 1Popular Prescription Drug Discount Card Now Available in Arizona Online 50974 2Popular Prescription Drug Discount Card Now Available in Arizona Online 50974 3Supplement Might Help Compulsive Hair Pullers 50970 1Supplement Might Help Compulsive Hair Pullers 50970 2Pharmacyclics Sets Record Date for Rights Offering 50966 1Pharmacyclics Sets Record Date for Rights Offering 50966 2Pharmacyclics Sets Record Date for Rights Offering 50966 3
...ational Institute of Allergy and Infectious Diseas...lth, has awarded UC Irvine $45 million over five y...wal grant, which is the campus,s largest ever, wen...llence for Biodefense and Emerging Infectious Dise... a UCI infectious disease expert. Created in May 2...
...man . , For the protection of the environment, a...vailable, renewable resources, such as specially c...te, are becoming the focus of considerable attenti...low the conversion of biomass into bio-oil, a high... German and Chinese scientists led by Johannes A. ...
...rk, May 12th, 2009 / b3c newswire / – R...today a technological breakthrough in the field of...i expression system. Richter-Helm BioLogics has ...nical trial material using 2nd Generation Expanded...Danish biotech company Upfront Chromatography A/...
Other Biology News:UCI awarded $45 million for infectious disease research 2Biomass as a source of raw materials 2NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA 2
CERTOMAT R from Sartorius AG
Affy Microarray Expression Analysis from Seqwright
...6 Microplate Luminometer has been designed,for t...,all measurements of glow and flash luminescence...ght remain nearly constant,over a longer period ...iring at least one injection during measurement. T...
...western blotting. Get results sooner and save hour...ion. Eliminates the need for a membrane transfer s...nts are ready-to-use. No reagents to prepare or mi.... Guarantees a simple to perform, mistake-free det...
Biology Products: